Breaking News Instant updates and real-time market news.

TPTX

Turning Point Therapeutics

$60.02 /

-0.5 (-0.83%)

17:28
07/13/20
07/13
17:28
07/13/20
17:28

Roth Capital positive on Turning Point Therapeutics appointment of Partridge

Roth Capital analyst Zegbeh Jallah keeps his Buy rating and $75 price target on Turning Point Therapeutics, saying the company's appointment of Andrew Partridge as Executive VP and Chief Commercial Officer represents a "strong addition to the team". The analyst is positive on the executive's over 20 years of pharmaceutical marketing and sales experience along with a strong track record of global commercial launches and multibillion-dollar marketing operations.

  • 06

    Sep

  • 19

    May

TPTX Turning Point Therapeutics
$60.02 /

-0.5 (-0.83%)

07/10/20
Fly Intel: Top five analyst initiations
07/09/20 Oppenheimer
Oppenheimer starts precision oncology 'upstart' Turning Point at Outperform
07/09/20 Roth Capital
Turning Point agreement with Zai Lab favorable, says Roth Capital
07/09/20 Oppenheimer
Turning Point Therapeutics initiated with an Outperform at Oppenheimer

TODAY'S FREE FLY STORIES

Options
Unusually active option classes on open August 6th » 09:40
08/06/20
08/06
09:40
08/06/20
09:40
BHC

Bausch Health

$19.45 /

+ (+0.00%)

, COMM

CommScope

$9.49 /

+ (+0.00%)

, BMY

Bristol-Myers

$59.69 /

+ (+0.00%)

, MRVL

Marvell

$37.79 /

+ (+0.00%)

, KNDI

Kandi Technologies

$8.66 /

+ (+0.00%)

, AAL

American Airlines

$12.55 /

-0.01 (-0.08%)

, SAVE

Spirit Airlines

$17.16 /

+ (+0.00%)

, FXI

iShares China Large-Cap ETF

$42.81 /

+ (+0.00%)

, MRK

Merck

$81.61 /

+ (+0.00%)

, SQ

Square

$146.46 /

+ (+0.00%)

Unusual total active…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BHC Bausch Health
$19.45 /

+ (+0.00%)

COMM CommScope
$9.49 /

+ (+0.00%)

BMY Bristol-Myers
$59.69 /

+ (+0.00%)

MRVL Marvell
$37.79 /

+ (+0.00%)

KNDI Kandi Technologies
$8.66 /

+ (+0.00%)

AAL American Airlines
$12.55 /

-0.01 (-0.08%)

SAVE Spirit Airlines
$17.16 /

+ (+0.00%)

MRK Merck
$81.61 /

+ (+0.00%)

SQ Square
$146.46 /

+ (+0.00%)

BHC Bausch Health
$19.45 /

+ (+0.00%)

06/17/20 H.C. Wainwright
Bausch Health price target raised to $64 from $50 at H.C. Wainwright
06/03/20 Jefferies
Duobrii could become a key revenue driver for Bausch Health, says Jefferies
04/24/20
Fly Intel: Top five analyst initiations
04/24/20 Citi
Bausch Health initiated with a Buy at Citi
COMM CommScope
$9.49 /

+ (+0.00%)

07/28/20 Raymond James
Corning results provide read-through to optical names, says Raymond James
07/24/20 Wolfe Research
CommScope initiated with an Outperform at Wolfe Research
07/07/20 Raymond James
CommScope downgraded to Market Perform at Raymond James on valuation
07/07/20 Raymond James
CommScope downgraded to Market Perform from Outperform at Raymond James
BMY Bristol-Myers
$59.69 /

+ (+0.00%)

07:23 Today Citi
Investors can refocus on Bristol-Myers story after Eliquis win, says Citi
07/28/20 Mizuho
Wait for Bristol-Myers' bb2121 submission making some 'nervous,' says Mizuho
07/28/20
Fly Intel: Top five analyst initiations
07/28/20 Raymond James
Bristol-Myers initiated with an Outperform at Raymond James
MRVL Marvell
$37.79 /

+ (+0.00%)

07/21/20 Piper Sandler
Marvell price target raised to $42 from $35 at Piper Sandler
07/15/20
Fly Intel: Top five analyst downgrades
07/15/20 Wells Fargo
Marvell downgraded to Equal Weight after recent rally at Wells Fargo
07/15/20 Wells Fargo
Marvell downgraded to Equal Weight from Overweight at Wells Fargo
KNDI Kandi Technologies
$8.66 /

+ (+0.00%)

AAL American Airlines
$12.55 /

-0.01 (-0.08%)

07/28/20 Citi
Citi cuts American Airlines target to $11, opens negative catalyst watch
07/27/20
Fly Intel: Top five analyst upgrades
07/27/20 Raymond James
American Airlines upgraded at Raymond James on balanced risk-reward
07/27/20 Raymond James
American Airlines upgraded to Market Perform from Underperform at Raymond James
SAVE Spirit Airlines
$17.16 /

+ (+0.00%)

07/09/20 Citi
Citi sees expectations for corporate travel rebound all but evaporating
06/29/20 Goldman Sachs
Spirit Airlines price target raised to $20 from $15 at Goldman Sachs
06/17/20
Fly Intel: Top five analyst initiations
06/17/20 Seaport Global
Spirit Airlines initiated with a Buy at Seaport Global
FXI iShares China Large-Cap ETF
$42.81 /

+ (+0.00%)

MRK Merck
$81.61 /

+ (+0.00%)

08/04/20 Piper Sandler
Merck deal sparks interest in GLP-1:glucagon agonists, says Piper Sandler
08/03/20
Fly Intel: Top five analyst upgrades
08/03/20 Goldman Sachs
Merck upgraded to Buy from Neutral at Goldman Sachs
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
SQ Square
$146.46 /

+ (+0.00%)

09:04 Today Susquehanna
Square price target raised to $180 from $145 at Susquehanna
08:58 Today Credit Suisse
Square price target raised to $170 from $80 at Credit Suisse
08:49 Today Wells Fargo
Square price target raised to $175 from $75 at Wells Fargo
08:17 Today Compass Point
Compass Point upgrades Square to Neutral on more resilience than expected
BHC Bausch Health
$19.45 /

+ (+0.00%)

COMM CommScope
$9.49 /

+ (+0.00%)

BMY Bristol-Myers
$59.69 /

+ (+0.00%)

MRVL Marvell
$37.79 /

+ (+0.00%)

KNDI Kandi Technologies
$8.66 /

+ (+0.00%)

AAL American Airlines
$12.55 /

-0.01 (-0.08%)

SAVE Spirit Airlines
$17.16 /

+ (+0.00%)

MRK Merck
$81.61 /

+ (+0.00%)

SQ Square
$146.46 /

+ (+0.00%)

  • 23
    Jun
  • 08
    May
BMY Bristol-Myers
$59.69 /

+ (+0.00%)

AAL American Airlines
$12.55 /

-0.01 (-0.08%)

SAVE Spirit Airlines
$17.16 /

+ (+0.00%)

MRK Merck
$81.61 /

+ (+0.00%)

SQ Square
$146.46 /

+ (+0.00%)

BHC Bausch Health
$19.45 /

+ (+0.00%)

COMM CommScope
$9.49 /

+ (+0.00%)

BMY Bristol-Myers
$59.69 /

+ (+0.00%)

MRVL Marvell
$37.79 /

+ (+0.00%)

KNDI Kandi Technologies
$8.66 /

+ (+0.00%)

AAL American Airlines
$12.55 /

-0.01 (-0.08%)

SAVE Spirit Airlines
$17.16 /

+ (+0.00%)

MRK Merck
$81.61 /

+ (+0.00%)

SQ Square
$146.46 /

+ (+0.00%)

BHC Bausch Health
$19.45 /

+ (+0.00%)

COMM CommScope
$9.49 /

+ (+0.00%)

BMY Bristol-Myers
$59.69 /

+ (+0.00%)

MRVL Marvell
$37.79 /

+ (+0.00%)

KNDI Kandi Technologies
$8.66 /

+ (+0.00%)

AAL American Airlines
$12.55 /

-0.01 (-0.08%)

SAVE Spirit Airlines
$17.16 /

+ (+0.00%)

FXI iShares China Large-Cap ETF
$42.81 /

+ (+0.00%)

MRK Merck
$81.61 /

+ (+0.00%)

SQ Square
$146.46 /

+ (+0.00%)

FXI iShares China Large-Cap ETF
$42.81 /

+ (+0.00%)

Downgrade
ResMed downgraded to Neutral from Buy at Goldman Sachs » 09:39
08/06/20
08/06
09:39
08/06/20
09:39
RMD

ResMed

$202.90 /

+0.28 (+0.14%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RMD ResMed
$202.90 /

+0.28 (+0.14%)

RMD ResMed
$202.90 /

+0.28 (+0.14%)

09:14 Today Oppenheimer
ResMed price target raised to $212 from $200 at Oppenheimer
08/03/20 BofA
ResMed downgraded to Underperform from Buy at BofA
06/17/20 Morgan Stanley
Morgan Stanley upgrades ResMed on faster shift to remote patient monitoring
06/17/20 Morgan Stanley
ResMed upgraded to Overweight from Equal Weight at Morgan Stanley
RMD ResMed
$202.90 /

+0.28 (+0.14%)

RMD ResMed
$202.90 /

+0.28 (+0.14%)

Recommendations
BioNTech price target raised to $69 from $42 at SVB Leerink » 09:37
08/06/20
08/06
09:37
08/06/20
09:37
BNTX

BioNTech

$81.28 /

-1.89 (-2.27%)

SVB Leerink analyst Daina…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/30/20 Morgan Stanley
Pfizer price target raised to $42 from $36 at Morgan Stanley
07/21/20
Fly Intel: Top five analyst upgrades
BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

  • 23
    Jul
  • 06
    Feb
  • 10
    Oct
BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

Hot Stocks
Kandi America announces distribution plans » 09:36
08/06/20
08/06
09:36
08/06/20
09:36
KNDI

Kandi Technologies

$8.66 /

-0.05 (-0.57%)

Kandi America, the U.S.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KNDI Kandi Technologies
$8.66 /

-0.05 (-0.57%)

KNDI Kandi Technologies
$8.66 /

-0.05 (-0.57%)

KNDI Kandi Technologies
$8.66 /

-0.05 (-0.57%)

KNDI Kandi Technologies
$8.66 /

-0.05 (-0.57%)

Recommendations
Progyny price target raised to $44 from $35 at SVB Leerink » 09:36
08/06/20
08/06
09:36
08/06/20
09:36
PGNY

Progyny

$27.55 /

+0.33 (+1.21%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PGNY Progyny
$27.55 /

+0.33 (+1.21%)

PGNY Progyny
$27.55 /

+0.33 (+1.21%)

06:32 Today Citi
Progyny price target raised to $32 from $28 at Citi
07/01/20 SVB Leerink
SVB Leerink bullish on Progyny, initiates with an Outperform
07/01/20 SVB Leerink
Progyny initiated with an Outperform at SVB Leerink
06/02/20 Guggenheim
Guggenheim starts Progyny at Buy, sees opportunity in pullback
PGNY Progyny
$27.55 /

+0.33 (+1.21%)

  • 25
    Oct
PGNY Progyny
$27.55 /

+0.33 (+1.21%)

Recommendations
Tabula Rasa HealthCare price target lowered to $56 from $65 at SVB Leerink » 09:34
08/06/20
08/06
09:34
08/06/20
09:34
TRHC

Tabula Rasa HealthCare

$49.61 /

-2.69 (-5.14%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRHC Tabula Rasa HealthCare
$49.61 /

-2.69 (-5.14%)

TRHC Tabula Rasa HealthCare
$49.61 /

-2.69 (-5.14%)

05:01 Today Piper Sandler
Tabula Rasa HealthCare price target lowered to $59 from $68 at Piper Sandler
07/02/20
Fly Intel: Top five analyst initiations
07/02/20 SunTrust
Tabula Rasa HealthCare initiated with a Buy at SunTrust
07/02/20 SunTrust
Tabula Rasa HealthCare initiated with a Buy at SunTrust
TRHC Tabula Rasa HealthCare
$49.61 /

-2.69 (-5.14%)

TRHC Tabula Rasa HealthCare
$49.61 /

-2.69 (-5.14%)

Upgrade
Weibo view upgraded to Mixed from Negative at OTR Global » 09:33
08/06/20
08/06
09:33
08/06/20
09:33
WB

Weibo

$35.94 /

+0.48 (+1.35%)

OTR Global upgraded the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WB Weibo
$35.94 /

+0.48 (+1.35%)

WB Weibo
$35.94 /

+0.48 (+1.35%)

07/07/20 Citi
New Wave could offer a 'bit more' for Sina, says Citi
05/20/20 HSBC
Weibo price target lowered to $34.50 from $38 at HSBC
05/06/20 OTR Global
Weibo downgraded to Negative from Mixed at OTR Global
04/22/20 Barclays
Weibo downgraded to Equal Weight from Overweight at Barclays
WB Weibo
$35.94 /

+0.48 (+1.35%)

WB Weibo
$35.94 /

+0.48 (+1.35%)

WB Weibo
$35.94 /

+0.48 (+1.35%)

WB Weibo
$35.94 /

+0.48 (+1.35%)

Recommendations
Nevro price target raised to $165 from $140 at SVB Leerink » 09:33
08/06/20
08/06
09:33
08/06/20
09:33
NVRO

Nevro

$137.38 /

+5.27 (+3.99%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVRO Nevro
$137.38 /

+5.27 (+3.99%)

NVRO Nevro
$137.38 /

+5.27 (+3.99%)

08:46 Today Wells Fargo
Nevro price target raised to $153 from $141 at Wells Fargo
06:31 Today Citi
Nevro price target raised to $160 from $137 at Citi
06/18/20 Morgan Stanley
Nevro price target raised to $145 from $135 at Morgan Stanley
06/08/20 UBS
Nevro upgraded to Neutral from Sell at UBS
NVRO Nevro
$137.38 /

+5.27 (+3.99%)

  • 02
    Apr
NVRO Nevro
$137.38 /

+5.27 (+3.99%)

Recommendations
Arena Pharmaceuticals price target raised to $91 from $73 at SVB Leerink » 09:31
08/06/20
08/06
09:31
08/06/20
09:31
ARNA

Arena Pharmaceuticals

$64.22 /

+0.66 (+1.04%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARNA Arena Pharmaceuticals
$64.22 /

+0.66 (+1.04%)

ARNA Arena Pharmaceuticals
$64.22 /

+0.66 (+1.04%)

08:30 Today Wells Fargo
Arena Pharmaceuticals price target raised to $78 from $60 at Wells Fargo
07/27/20 Citi
Arena Pharmaceuticals price target raised to $83 from $65 at Citi
06/29/20 H.C. Wainwright
Arena Pharmaceuticals initiated with a Buy at H.C. Wainwright
06/02/20 Credit Suisse
Arena Pharmaceuticals price target raised to $87 from $77 at Credit Suisse
ARNA Arena Pharmaceuticals
$64.22 /

+0.66 (+1.04%)

  • 28
    May
ARNA Arena Pharmaceuticals
$64.22 /

+0.66 (+1.04%)

Upgrade
Enable Midstream upgraded to Outperform from Peer Perform at Wolfe Research » 09:31
08/06/20
08/06
09:31
08/06/20
09:31
ENBL

Enable Midstream

$5.26 /

+0.335 (+6.81%)

Wolfe Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ENBL Enable Midstream
$5.26 /

+0.335 (+6.81%)

ENBL Enable Midstream
$5.26 /

+0.335 (+6.81%)

07/07/20 UBS
OGE Energy upgraded to Buy from Neutral at UBS
05/08/20 BofA
OGE Energy upgraded to Buy from Neutral at BofA
05/06/20 RF Lafferty
Enable Midstream downgraded to Hold from Buy at RF Lafferty
05/04/20 Mizuho
Enable Midstream price target lowered to $8 from $14 at Mizuho
ENBL Enable Midstream
$5.26 /

+0.335 (+6.81%)

ENBL Enable Midstream
$5.26 /

+0.335 (+6.81%)

Hot Stocks
Inseego appoints Craig Foster as CFO » 09:30
08/06/20
08/06
09:30
08/06/20
09:30
INSG

Inseego

$14.76 /

+0.23 (+1.58%)

Inseego said in a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INSG Inseego
$14.76 /

+0.23 (+1.58%)

INSG Inseego
$14.76 /

+0.23 (+1.58%)

09:16 Today Lake Street
Inseego price target raised to $17 from $13 at Lake Street
09:01 Today Roth Capital
Inseego downgraded to Neutral on valuation at Roth Capital
08:25 Today Northland
Inseego downgraded to Market Perform on valuation at Northland
08:13 Today Northland
Inseego downgraded to Market Perform from Outperform at Northland
INSG Inseego
$14.76 /

+0.23 (+1.58%)

INSG Inseego
$14.76 /

+0.23 (+1.58%)

INSG Inseego
$14.76 /

+0.23 (+1.58%)

Recommendations
Silk Road Medical price target raised to $60 from $51 at SVB Leerink » 09:29
08/06/20
08/06
09:29
08/06/20
09:29
SILK

Silk Road Medical

$49.96 /

+1.61 (+3.33%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SILK Silk Road Medical
$49.96 /

+1.61 (+3.33%)

SILK Silk Road Medical
$49.96 /

+1.61 (+3.33%)

06:33 Today Citi
Silk Road Medical price target raised to $58 from $50 at Citi
07/09/20
Fly Intel: Top five analyst initiations
07/09/20 SVB Leerink
Silk Road Medical initiated with an Outperform at SVB Leerink
05/27/20 Citi
Silk Road Medical initiated with a Buy at Citi
SILK Silk Road Medical
$49.96 /

+1.61 (+3.33%)

  • 06
    May
  • 09
    Aug
Initiation
Sherritt reinstated with a Hold at TD Securities » 09:28
08/06/20
08/06
09:28
08/06/20
09:28
SHERF

Sherritt

$0.00 /

+ (+0.00%)

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Adaptive Biotechnologies receives expanded FDA clearance for clonoSEQ Assay » 09:28
08/06/20
08/06
09:28
08/06/20
09:28
ADPT

Adaptive Biotechnologies

$39.91 /

-0.39 (-0.97%)

Adaptive Biotechnologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADPT Adaptive Biotechnologies
$39.91 /

-0.39 (-0.97%)

ADPT Adaptive Biotechnologies
$39.91 /

-0.39 (-0.97%)

06/18/20 Guggenheim
Adaptive to benefit from increased MRD testing by oncologists, says Guggenheim
06/03/20
Fly Intel: Top five analyst initiations
06/03/20 Goldman Sachs
Adaptive Biotechnologies initiated with a Buy at Goldman Sachs
05/19/20 Guggenheim
Adaptive Biotechnologies price target raised to $50 from $44 at Guggenheim
ADPT Adaptive Biotechnologies
$39.91 /

-0.39 (-0.97%)

  • 16
    Jul
  • 24
    Jan
ADPT Adaptive Biotechnologies
$39.91 /

-0.39 (-0.97%)

Recommendations
Morgan Stanley stays Underweight on Etsy, wonder is this 'as good as it gets?' » 09:28
08/06/20
08/06
09:28
08/06/20
09:28
ETSY

Etsy

$135.64 /

+5.78 (+4.45%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ETSY Etsy
$135.64 /

+5.78 (+4.45%)

ETSY Etsy
$135.64 /

+5.78 (+4.45%)

09:13 Today Truist
Etsy price target raised to $162 from $112 at Truist
08:56 Today Canaccord
Etsy price target raised to $160 from $130 at Canaccord
08:54 Today Needham
Etsy price target raised to $150 from $130 at Needham
07:54 Today Wedbush
Etsy price target raised to $155 from $115 at Wedbush
ETSY Etsy
$135.64 /

+5.78 (+4.45%)

ETSY Etsy
$135.64 /

+5.78 (+4.45%)

ETSY Etsy
$135.64 /

+5.78 (+4.45%)

ETSY Etsy
$135.64 /

+5.78 (+4.45%)

Recommendations
Humana price target raised to $496 from $465 at SVB Leerink » 09:27
08/06/20
08/06
09:27
08/06/20
09:27
HUM

Humana

$404.02 /

+12.83 (+3.28%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HUM Humana
$404.02 /

+12.83 (+3.28%)

HUM Humana
$404.02 /

+12.83 (+3.28%)

09:16 Today Oppenheimer
Humana price target raised to $440 from $425 at Oppenheimer
07/27/20 BofA
Accolade initiated with a Buy at BofA
07/23/20 Evercore ISI
Evercore ISI says Humana pact relates to FIT testing, not Exact's Cologuard
07/23/20 Evercore ISI
Humana plans could boost Exact's growth as much as 12%, says Evercore ISI
HUM Humana
$404.02 /

+12.83 (+3.28%)

HUM Humana
$404.02 /

+12.83 (+3.28%)

HUM Humana
$404.02 /

+12.83 (+3.28%)

HUM Humana
$404.02 /

+12.83 (+3.28%)

Initiation
Digital Realty initiated with a Hold at TD Securities » 09:26
08/06/20
08/06
09:26
08/06/20
09:26
DLR

Digital Realty

$159.66 /

-1.39 (-0.86%)

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DLR Digital Realty
$159.66 /

-1.39 (-0.86%)

DLR Digital Realty
$159.66 /

-1.39 (-0.86%)

07/31/20 Raymond James
Digital Realty upgraded to Outperform from Market Perform at Raymond James
07/31/20 Raymond James
Digital Realty upgraded to Outperform from Market Perform at Raymond James
07/15/20 Barclays
Digital Realty initiated with an Overweight at Barclays
07/14/20 Edward Jones
Digital Realty initiated with a Hold at Edward Jones
DLR Digital Realty
$159.66 /

-1.39 (-0.86%)

DLR Digital Realty
$159.66 /

-1.39 (-0.86%)

DLR Digital Realty
$159.66 /

-1.39 (-0.86%)

Recommendations
GoDaddy price target raised to $95 from $88 at Truist » 09:26
08/06/20
08/06
09:26
08/06/20
09:26
GDDY

GoDaddy

$74.46 /

+1.125 (+1.53%)

Truist analyst Naved Khan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GDDY GoDaddy
$74.46 /

+1.125 (+1.53%)

GDDY GoDaddy
$74.46 /

+1.125 (+1.53%)

08:55 Today JPMorgan
JPMorgan upgrades GoDaddy to Overweight with $110 price target
07:57 Today Deutsche Bank
GoDaddy price target raised to $92 from $85 at Deutsche Bank
06:21 Today Raymond James
GoDaddy upgraded to Strong Buy at Raymond James after 'solid' Q2 results
04:46 Today Raymond James
GoDaddy upgraded to Strong Buy from Outperform at Raymond James
GDDY GoDaddy
$74.46 /

+1.125 (+1.53%)

GDDY GoDaddy
$74.46 /

+1.125 (+1.53%)

GDDY GoDaddy
$74.46 /

+1.125 (+1.53%)

Initiation
SVB Leerink bullish on Zymeworks, initiates with an Outperform » 09:25
08/06/20
08/06
09:25
08/06/20
09:25
ZYME

Zymeworks

/

+

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZYME Zymeworks
/

+

ZYME Zymeworks
/

+

06:12 Today SVB Leerink
Zymeworks initiated with an Outperform at SVB Leerink
07/14/20 Guggenheim
Zymeworks price target lowered to $48, removed as Best Idea at Guggenheim
07/13/20 Canaccord
Zymeworks price target raised to $42 from $25 at Canaccord
07/09/20 H.C. Wainwright
Zymeworks 'evasiveness' not what Street wanted, says H.C. Wainwright
ZYME Zymeworks
/

+

  • 23
    Jan
Initiation
CyrusOne initiated with a Buy at TD Securities » 09:25
08/06/20
08/06
09:25
08/06/20
09:25
CONE

CyrusOne

$86.50 /

+1.7 (+2.00%)

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CONE CyrusOne
$86.50 /

+1.7 (+2.00%)

CONE CyrusOne
$86.50 /

+1.7 (+2.00%)

08/04/20 Credit Suisse
CyrusOne price target raised to $92 from $78 at Credit Suisse
08/03/20 Deutsche Bank
CyrusOne price target raised to $88 from $83 at Deutsche Bank
07/15/20 SunTrust
CyrusOne price target raised to $90 from $82 at SunTrust
07/15/20 Barclays
CyrusOne initiated with an Equal Weight at Barclays
CONE CyrusOne
$86.50 /

+1.7 (+2.00%)

CONE CyrusOne
$86.50 /

+1.7 (+2.00%)

CONE CyrusOne
$86.50 /

+1.7 (+2.00%)

Initiation
Equinix initiated with a Hold at TD Securities » 09:23
08/06/20
08/06
09:23
08/06/20
09:23
EQIX

Equinix

$794.51 /

+0.27 (+0.03%)

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EQIX Equinix
$794.51 /

+0.27 (+0.03%)

EQIX Equinix
$794.51 /

+0.27 (+0.03%)

08/05/20 Deutsche Bank
Equinix price target raised to $850 from $760 at Deutsche Bank
07/30/20 Wells Fargo
Equinix price target raised to $840 from $790 at Wells Fargo
07/30/20 JPMorgan
Equinix price target raised to $861 from $725 at JPMorgan
07/30/20 Credit Suisse
Equinix price target raised to $782 from $704 at Credit Suisse
EQIX Equinix
$794.51 /

+0.27 (+0.03%)

  • 12
    May
EQIX Equinix
$794.51 /

+0.27 (+0.03%)

EQIX Equinix
$794.51 /

+0.27 (+0.03%)

Hot Stocks
Ceridian appoints Joe Korngiebel as EVP, chief product and technology officer » 09:22
08/06/20
08/06
09:22
08/06/20
09:22
CDAY

Ceridian

$84.27 /

+1.88 (+2.28%)

, WDAY

Workday

$184.16 /

+2.68 (+1.48%)

Ceridian (CDAY) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CDAY Ceridian
$84.27 /

+1.88 (+2.28%)

WDAY Workday
$184.16 /

+2.68 (+1.48%)

CDAY Ceridian
$84.27 /

+1.88 (+2.28%)

08:36 Today Wells Fargo
Ceridian price target raised to $93 from $72 at Wells Fargo
08:29 Today Needham
Ceridian price target raised to $94 from $70 at Needham
06:43 Today Mizuho
Ceridian price target raised to $100 from $85 at Mizuho
06:01 Today CIBC
Ceridian downgraded to Neutral on near term headwinds at CIBC
WDAY Workday
$184.16 /

+2.68 (+1.48%)

06/25/20 RBC Capital
Workday price target raised to $210 from $200 at RBC Capital
06/24/20 Goldman Sachs
Workday price target raised to $210 from $181 at Goldman Sachs
05/28/20 JPMorgan
Workday price target raised to $190 from $175 at JPMorgan
05/28/20 Needham
Workday price target raised to $200 from $175 at Needham
CDAY Ceridian
$84.27 /

+1.88 (+2.28%)

WDAY Workday
$184.16 /

+2.68 (+1.48%)

  • 09
    Jun
  • 21
    May
  • 13
    Nov
  • 05
    Sep
  • 07
    Aug
CDAY Ceridian
$84.27 /

+1.88 (+2.28%)

WDAY Workday
$184.16 /

+2.68 (+1.48%)

WDAY Workday
$184.16 /

+2.68 (+1.48%)

Recommendations
Fastly price target raised to $105 from $85 at Baird » 09:22
08/06/20
08/06
09:22
08/06/20
09:22
FSLY

Fastly

$108.92 /

-7.26 (-6.25%)

Baird analyst William…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FSLY Fastly
$108.92 /

-7.26 (-6.25%)

FSLY Fastly
$108.92 /

-7.26 (-6.25%)

09:07 Today Oppenheimer
Fastly downgraded to Perform on valuation at Oppenheimer
08:55 Today Credit Suisse
Fastly price target raised to $100 from $32 at Credit Suisse
06:12 Today Oppenheimer
Fastly downgraded to Perform from Outperform at Oppenheimer
06:08 Today Piper Sandler
Fastly exposure to TikTok larger than expected, says Piper Sandler
FSLY Fastly
$108.92 /

-7.26 (-6.25%)

  • 21
    May
FSLY Fastly
$108.92 /

-7.26 (-6.25%)

FSLY Fastly
$108.92 /

-7.26 (-6.25%)

Recommendations
UPS price target raised to $153 from $106 at Oppenheimer » 09:21
08/06/20
08/06
09:21
08/06/20
09:21
UPS

UPS

$145.05 /

+0.42 (+0.29%)

Oppenheimer analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UPS UPS
$145.05 /

+0.42 (+0.29%)

UPS UPS
$145.05 /

+0.42 (+0.29%)

08/03/20 Standpoint Research
UPS downgraded to Hold from Buy at Standpoint Research
08/03/20 Stephens
UPS price target raised to $150 from $105 at Stephens
07/31/20 BMO Capital
UPS price target raised to $115 from $95 at BMO Capital
07/31/20 Deutsche Bank
UPS price target raised to $160 from $119 at Deutsche Bank
UPS UPS
$145.05 /

+0.42 (+0.29%)

UPS UPS
$145.05 /

+0.42 (+0.29%)

UPS UPS
$145.05 /

+0.42 (+0.29%)

UPS UPS
$145.05 /

+0.42 (+0.29%)

Recommendations
OptimizeRx price target raised to $20 from $17 at Lake Street » 09:21
08/06/20
08/06
09:21
08/06/20
09:21
OPRX

OptimizeRx

$15.50 /

+0.07 (+0.45%)

Lake Street analyst Eric…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OPRX OptimizeRx
$15.50 /

+0.07 (+0.45%)

OPRX OptimizeRx
$15.50 /

+0.07 (+0.45%)

08:31 Today B. Riley FBR
OptimizeRx price target raised to $28 from $22 at B. Riley FBR
06/10/20 Lake Street
OptimizeRx news strategically significant, broadens reach, says Lake Street
06/08/20 Lake Street
OptimizeRx price target raised to $17 from $14 at Lake Street
05/05/20 B. Riley FBR
OptimizeRx price target raised to $22 from $18 at B. Riley FBR
OPRX OptimizeRx
$15.50 /

+0.07 (+0.45%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.